Hematological monitoring in patients receiving aminosalicylates.
Yarze
J C
JC
Chase
M P
MP
Fritz
H P
HP
Herlihy
K J
KJ
D000284:Administration, Oral; D000285:Administration, Rectal; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016903:Drug Monitoring; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D019804:Mesalamine / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D013256:Steroids; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis
D000893:Anti-Inflammatory Agents; D013256:Steroids; D019804:Mesalamine